SUSRF (Surgical Science Sweden AB) GF Value Rank: 2 (As of Jul. 11, 2026) — 50% Below Median


SUSRF Surgical Science Sweden AB SUSRF
82 GF Score
Price $4.00
GF Value $14.24
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB GF Value Rank?

Surgical Science Sweden AB SUSRF -2.20% 82 GF Value Rank is 2 as of Jul. 11, 2026, which is 50% below its 10-year median of 4.00. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.24 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Surgical Science Sweden AB has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Surgical Science Sweden AB GF Value Rank Related Terms

SUSRF vs VEEV, BTSG, TEM: GF Value Rank Comparison

For the Health Information Services subindustry, Surgical Science Sweden AB's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Science Sweden AB GF Value Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's GF Value Rank falls into.


SUSRF
82GF Score
Surgical Science Sweden AB SUSRF
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
Surgical Science Sweden AB (SUSRF) has a GF Value Rank of 2 as of Jul. 11, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Surgical Science Sweden AB and its competitors. This is 50% below median its historical median of 4.00. Over the past decade, Surgical Science Sweden AB's GF Value Rank has ranged from 1.00 to 10.00.
Is Surgical Science Sweden AB's GF Value Rank too high?
Surgical Science Sweden AB's current GF Value Rank of 2 is 50% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's GF Value Rank compare to VEEV and BTSG?
Surgical Science Sweden AB's GF Value Rank of 2 can be compared against companies in the Healthcare Providers & Services industry. Historically, Surgical Science Sweden AB's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Healthcare Providers & Services company?
A good GF Value Rank depends on the Healthcare Providers & Services industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current GF Value Rank is 2, which is 50% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.24, compared to a current price of $4.00 — trading 71.9% below its estimated fair value. The current GF Value Rank is 2, which is 50% below median its 10-year median of 4.00. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current GF Value Rank is 2 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 71.9% below its estimated GF Value™ of $14.24. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for SUSRF:

  • GF Value Rank: 2 (50% below median its 10-year median of 4.00)
  • GF Value™: $14.24 vs. price of $4.00 (71.9% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score

Get the complete analysis for SUSRF

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$14.24
GF Value